Dow Down0.30% Nasdaq Up0.18%

Cardiome Pharma Corp. (CRME)

-NasdaqCM
6.75 Down 0.16(2.32%) 2:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 4,511   789   1,505  
Cost of Revenue936   -   -  
Gross Profit 3,575   789   1,505  
Operating Expenses
Research Development476  6,017  15,224  
Selling General and Administrative16,446  9,463  11,549  
Non Recurring2,701  10,040  95  
Others649  1,229  1,095  
Total Operating Expenses20,272  26,749  27,963  
Operating Income or Loss (16,697) (25,960) (26,458)
Income from Continuing Operations
Total Other Income/Expenses Net21,659  11,913  756  
Earnings Before Interest And Taxes4,962  (14,047)(25,702)
Interest Expense87  4,268  2,218  
Income Before Tax4,875  (18,315)(27,920)
Income Tax Expense102   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops25,607  (7,097)(27,920)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 4,773   (18,315) (27,920)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 4,773   (18,315) (27,920)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.